These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21324546)

  • 21. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
    Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
    J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of hyper IgE syndrome.
    Heimall J; Freeman A; Holland SM
    Clin Rev Allergy Immunol; 2010 Feb; 38(1):32-8. PubMed ID: 19452285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyper-IgE syndromes: recent advances in pathogenesis, diagnostics and clinical care.
    Farmand S; Sundin M
    Curr Opin Hematol; 2015 Jan; 22(1):12-22. PubMed ID: 25469836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel hemizygous CD40L mutation of X-linked hyper IgM syndromes and compound heterozygous DOCK8 mutations of hyper IgE syndromes in two Chinese families.
    Guo M; Ma Y; Cai K; Liu X; Liu W; Wang F; Qu N; Liu S
    Immunogenetics; 2024 Jun; 76(3):165-173. PubMed ID: 38587548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human hyper-IgE syndrome: singular or plural?
    Zhang Q; Boisson B; Béziat V; Puel A; Casanova JL
    Mamm Genome; 2018 Aug; 29(7-8):603-617. PubMed ID: 30094507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the hyper-IgE syndromes.
    Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
    Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome.
    Mohammadi T; Azizi G; Rafiemanesh H; Farahani P; Nirouei M; Tavakol M
    Clin Exp Med; 2023 Dec; 23(8):4835-4859. PubMed ID: 37924455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic alterations compromised molecular diagnosis of DOCK8 hyper-IgE syndrome caused by a novel intronic splice site mutation.
    Hagl B; Spielberger BD; Thoene S; Bonnal S; Mertes C; Winter C; Nijman IJ; Verduin S; Eberherr AC; Puel A; Schindler D; Ruland J; Meitinger T; Gagneur J; Orange JS; van Gijn ME; Renner ED
    Sci Rep; 2018 Nov; 8(1):16719. PubMed ID: 30425284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
    Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
    J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
    Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
    J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperimmunoglobulin E syndromes in pediatrics.
    Zhang Q; Su HC
    Curr Opin Pediatr; 2011 Dec; 23(6):653-8. PubMed ID: 21970826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.
    Engelhardt KR; McGhee S; Winkler S; Sassi A; Woellner C; Lopez-Herrera G; Chen A; Kim HS; Lloret MG; Schulze I; Ehl S; Thiel J; Pfeifer D; Veelken H; Niehues T; Siepermann K; Weinspach S; Reisli I; Keles S; Genel F; Kutukculer N; Camcioğlu Y; Somer A; Karakoc-Aydiner E; Barlan I; Gennery A; Metin A; Degerliyurt A; Pietrogrande MC; Yeganeh M; Baz Z; Al-Tamemi S; Klein C; Puck JM; Holland SM; McCabe ER; Grimbacher B; Chatila TA
    J Allergy Clin Immunol; 2009 Dec; 124(6):1289-302.e4. PubMed ID: 20004785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel large deletion of the DOCK8 gene in a Chinese family with autosomal-recessive hyper-IgE syndrome.
    Xue L; Yang Y; Wang S
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):599-601. PubMed ID: 24673638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic origins of hyper-IgE syndrome.
    Minegishi Y; Karasuyama H
    Curr Allergy Asthma Rep; 2008 Sep; 8(5):386-91. PubMed ID: 18682102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DOCK8 mutation diagnosed using whole-exome sequencing of the dried blood spot-derived DNA: a case report of an Iraqi girl diagnosed in Japan.
    Al-Kzayer LFY; Al-Aradi HMH; Shigemura T; Sano K; Tanaka M; Hamada M; Ali KH; Aldaghir OM; Nakazawa Y; Okuno Y
    BMC Med Genet; 2019 Jun; 20(1):114. PubMed ID: 31242861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES).
    Heimall J; Davis J; Shaw PA; Hsu AP; Gu W; Welch P; Holland SM; Freeman AF
    Clin Immunol; 2011 Apr; 139(1):75-84. PubMed ID: 21288777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confirmation of Hyperimmunoglobulin E Syndrome in Two Patients with an Ocular Problem: Detection of Two New DOCK8 Mutations.
    Saghafi S; Zandieh F; Fazlollahi MR; Glocker C; Frede N; Buchta M; Yang L; Mahmoudi AH; Houshmand M; Pourpak Z; Grimbacher B; Moin M
    Iran J Allergy Asthma Immunol; 2022 Jun; 21(3):355-363. PubMed ID: 35822685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Role of
    Moffitt K; Cheung E; Manis J; Malley R
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29463618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3.
    Steward-Tharp SM; Laurence A; Kanno Y; Kotlyar A; Villarino AV; Sciume G; Kuchen S; Resch W; Wohlfert EA; Jiang K; Hirahara K; Vahedi G; Sun HW; Feigenbaum L; Milner JD; Holland SM; Casellas R; Powrie F; O'Shea JJ
    Blood; 2014 May; 123(19):2978-87. PubMed ID: 24632714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.
    Aydin SE; Kilic SS; Aytekin C; Kumar A; Porras O; Kainulainen L; Kostyuchenko L; Genel F; Kütükcüler N; Karaca N; Gonzalez-Granado L; Abbott J; Al-Zahrani D; Rezaei N; Baz Z; Thiel J; Ehl S; Marodi L; Orange JS; Sawalle-Belohradsky J; Keles S; Holland SM; Sanal Ö; Ayvaz DC; Tezcan I; Al-Mousa H; Alsum Z; Hawwari A; Metin A; Matthes-Martin S; Hönig M; Schulz A; Picard C; Barlogis V; Gennery A; Ifversen M; van Montfrans J; Kuijpers T; Bredius R; Dückers G; Al-Herz W; Pai SY; Geha R; Notheis G; Schwarze CP; Tavil B; Azik F; Bienemann K; Grimbacher B; Heinz V; Gaspar HB; Aydin R; Hagl B; Gathmann B; Belohradsky BH; Ochs HD; Chatila T; Renner ED; Su H; Freeman AF; Engelhardt K; Albert MH;
    J Clin Immunol; 2015 Feb; 35(2):189-98. PubMed ID: 25627830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.